Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Copolymerization and polymer blending of trimethylene carbonate and adipic anhydride for tailored drug delivery
KTH, Tidigare Institutioner                               , Polymerteknologi.ORCID-id: 0000-0002-1631-1781
KTH, Tidigare Institutioner                               , Polymerteknologi.ORCID-id: 0000-0001-8696-9143
1999 (Engelska)Ingår i: Journal of Applied Polymer Science, ISSN 0021-8995, E-ISSN 1097-4628, Vol. 72, nr 2, s. 227-239Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

The copolymerization in bulk and solution of trimethylene carbonate (TMC) with adipic anhydride (AA) as well as the blending of homopolymers are described. We show experimentally that the components are not copolymerizable but partially miscible, forming a microscopic dispersion without any visible signs of phase separation. Poly(adipic anhydride) (PAA) functions as a plasticizer, permitting an increase in the erosion rate by increasing the porosity and hydration. Drug delivery from the blends was evaluated. A statistical factorial model was designed to explore the influence of three important blend parameters and their interactions, making it possible to predict the erosion and drug-release behavior of the blend matrices. The PAA:poly(trimethylene carbonate) (PTMC) ratio and molecular weight of the polycarbonate component significantly influence the drug-release performance, mass loss, and degree of plasticization. The interaction among these factors also influences the blend properties. Plasticization of PTMC enhances the drug release to an extent that is dependent on the amount of PAA used. We demonstrate that blending offers a convenient alternative to copolymerization for the preparation of polymer matrices with predictable drug delivery.

Ort, förlag, år, upplaga, sidor
1999. Vol. 72, nr 2, s. 227-239
Nyckelord [en]
screening design, poly(trimethylene carbonate), poly(adipic acid), drug delivery, degradable blend, copolymerization, RELEASE CHARACTERISTICS, POLY(ADIPIC ANHYDRIDE), DEGRADATION, MICROSPHERES, POLYANHYDRIDES, MATRICES
Nationell ämneskategori
Polymerkemi
Identifikatorer
URN: urn:nbn:se:kth:diva-13121ISI: 000078984800008OAI: oai:DiVA.org:kth-13121DiVA, id: diva2:321006
Anmärkning
QC 20100528Tillgänglig från: 2010-05-28 Skapad: 2010-05-28 Senast uppdaterad: 2020-01-08Bibliografiskt granskad
Ingår i avhandling
1. Design of new biodegradable polymer matrices for controlled drug delivery
Öppna denna publikation i ny flik eller fönster >>Design of new biodegradable polymer matrices for controlled drug delivery
2000 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Conventional drug administration technologies display poorcontrollability, and lead to high plasma concentrations andshort duration times, which frequently lead to adverse effects.Controlled release technology aims at predictable andreproducible delivery of an active substance over an extendedperiod of time, yielding optimal response and prolongedefficiency, and thus offering considerable improvement of manytreatments. A powerful approach to controlled drug delivery isthe incorporation of the drug into a biodegradable polymericmatrix, which distributes the active substance in a controlledand sustained fashion as the polymer erodes.

This thesis describes the design of novel biodegradablepolymer matrices for controlled and sustained drug delivery.New functional and biodegradable materials with variableproperties were obtained by homopolymer blending andcopolymerization of building blocks with specific, desirableproperties; poly(adipic anhydride) (PAA), poly(trimethylenecarbonate) (PTMC), poly(1,5-dioxepan-2-one) (PDXO),poly(L-lactide) (PLLA), poly(D,L-lactide) (PDLLA), andpoly(L-lactide-co-1,5-dioxepan-2-one) (P(L-LA-co-DXO).Techniques were developed for the preparation of drug-releasingmatrices in the form of films and microspheres. Variousanalysis techniques, including Differential ScanningCalorimetry,1H-Nuclear Magnetic Resonance, InfraredSpectrometry, Scanning Electron Microscopy, Size ExclusionChromatography and UV-VIS Spectroscopy, were used forcharacterization.

Microspheres encapsulating therapeutic substances wereprepared from P(L-LA-co-DXO) and blends of PDXO with PLLA orPDLLA. The properties, storage stability,degradation and drugrelease characteristics of these matrices were explored,compared and evaluated with special regard to the morphologyand its impact on thein vitrobehavior. Sustained release of drugs wasobtained. The mode of release was strongly influenced by thehydrophilicity of the drug, and by the copolymer/blendcomposition and morphology. The lactide:DXO composition wasproven to be a versatile tool to control the morphology and inturn the rates and pattern of erosion and diffusion ofencapsulated agents from the matrices.

Films were prepared from PTMC-PAA blends, in which PAA actedas a plasticizer. Loss of the fast-degrading PAA componentenhanced the porosity and hydration of the slow-degrading PTMC.A statistical full factorial model was designed to elucidatethe influence of matrix parameters and their interactions. ThePTMC-PAA ratio, the molecular weight of the PTMC, andinteractions amongst these factors significantly influenced therelease performance, mass loss and degree of plasticization andthe relationships obtained enabled the erosion and drug releasepattern to be predicted and controlled. Moisture uptake,storage stability at different relative humidities, and thesterilizability were determined to further explore theversatility of PTMC-PAA matrices. Thein vivolocal tissue response and biocompatibility ofPTMC-PAA implants was assessed in the anterior chamber ofrabbits eyes for 1 month. PTMC-rich matrices displayed goodbiocompatibility.

Key factors that regulate the biological activity of thesepolymeric vehicles were identified as drug solubility,composition, molecular weight, stereochemical configuration,and morphology. By careful design, the degradation and drugrelease characteristics, e.g. kinetics and duration, can bealtered over a broad spectrum. This study shows that structuralchanges of the polymer backbone, and the modeling ofcomposition and morphology provide powerful means of tailoringsystems for specific applications.

Keywords: controlled release, drug delivery, microspheres,polylactide, poly(1,5-dioxepan-2-one), poly(adipic anhydride),poly(trimethylene carbonate), degradation, blends

Ort, förlag, år, upplaga, sidor
Stockholm: KTH, 2000. s. 118
Nationell ämneskategori
Polymerkemi
Identifikatorer
urn:nbn:se:kth:diva-2949 (URN)91-7170-534-1 (ISBN)
Disputation
2000-04-14, 00:00 (Engelska)
Anmärkning
QC 20100528Tillgänglig från: 2000-04-18 Skapad: 2000-04-18 Senast uppdaterad: 2010-05-28Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Personposter BETA

Edlund, Ulrica

Sök vidare i DiVA

Av författaren/redaktören
Edlund, UlricaAlbertsson, Ann-Christine
Av organisationen
Polymerteknologi
I samma tidskrift
Journal of Applied Polymer Science
Polymerkemi

Sök vidare utanför DiVA

GoogleGoogle Scholar

urn-nbn

Altmetricpoäng

urn-nbn
Totalt: 314 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf